πŸ‡ΊπŸ‡Έ FDA
Patent

US 12296053

Nanomaterials comprising triols

granted A61KA61K39/385A61K48/0033

Quick answer

US patent 12296053 (Nanomaterials comprising triols) held by Beam Therapeutics Inc. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beam Therapeutics Inc.
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K39/385, A61K48/0033, A61K9/5015, A61K9/5123